Syngene International Ltd Share Price

Overview

Syngene International Ltd share price is currently ₹391.80, down by - ₹9.48 (2.36%) from its previous closing price of ₹401.28. The share price has declined -2.33% over the past month and declined -40.44% over the past year. The stock's 52-week low and high are ₹368.12 and ₹668.64, respectively. Syngene International Ltd has a market capitalisation of ₹ 16,370.00 Cr. The share price was last updated on 24 Aug 2026, 03:51 PM IST.

Syngene International Ltd
Syngene International Ltd
SYNGENE
 0.00
- 9.48
2.36%
Healthcare
 0.00(%)1D

Updated: 24 Aug 2026, 03:51:44 pm IST

Market Data

Open Price

 394.00

Prev. Close

 401.28
 390.73

Day Low

 395.49

Day High

 368.12

52 Week Low

 668.64

52 Week High

HealthcareBusiness Support
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

71.37

Sector PE

42.03

PB Ratio

3.33

Sector PB

5.82

EPS

5.49

Dividend Yield

0.32

Today's Volume

271.737 K

5 Day Avg. Volume

760.819 K

PEG Ratio

-1.97

Market Cap.

₹ 16,370.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 12.5% at ₹1.25/Share
25-Jun-202626-Jun-2026
DividendsFinal Dividend of 12.5% at ₹1.25/Share
27-Jun-202527-Jun-2025

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
Nippon India Small Cap Fund - Growth1.25 Cr
1.25 Cr
no change
SBI Multi Asset Allocation Fund - Regular Plan - Growth70.00 Lac
70.00 Lac
no change
Nippon India Multi Cap Fund - Growth65.81 Lac
65.81 Lac
no change
ICICI Prudential Multicap Fund - Growth50.69 Lac
65.69 Lac
(29.59%)
Nippon India Focused Fund - Growth57.46 Lac
59.96 Lac
(4.35%)

About Syngene International Ltd 👋

Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The Company's services include discovery, development, manufacturing, SynVent Integrated Drug discovery, dedicated centers, and Center for Advanced Protein Studies (CAPS). Its discovery services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. It offers preclinical development, active pharmaceutical ingredient and drug product development for both small molecules and biologics. It has capabilities for current Good Manufacturing Practices (cGMP) manufacturing from benchtop volume to commercial scale. SynVent is its drug discovery platform for enabling fully integrated therapeutic drug discovery and development across small molecules, new modalities and biologics.

News & Events

Frequently Asked Questions

What is the share price of Syngene International Ltd?

What is the market cap of Syngene International Ltd?

Should I buy Syngene International Ltd stock now?

What is the 52 week high and low of Syngene International Ltd?

Is the Syngene International Ltd stock good to buy?

Is Syngene International Ltd a good buy for the long term?

Is Syngene International Ltd overvalued or undervalued?

What is the PE and PB ratio of Syngene International Ltd?

Start Now